Citizens & Northern Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-4,762
Closed -$714K 106
2016
Q1
$714K Buy
4,762
+128
+3% +$19K 0.56% 64
2015
Q4
$752K Sell
4,634
-220
-5% -$34.6K 0.61% 61
2015
Q3
$671K Sell
4,854
-3,340
-41% -$526K 0.52% 68
2015
Q2
$1.26M Buy
8,194
+262
+3% +$42K 0.97% 35
2015
Q1
$1.27M Buy
7,932
+877
+12% +$138K 0.96% 34
2014
Q4
$1.12M Buy
+7,055
New +$1.1M 0.85% 41

Other funds holding AMGN

Citizens & Northern Corp's AMGN Position: Q2 2016 in Review

Citizens & Northern Corp sold out of Amgen (AMGN) in Q2 2016, closing a stake of 4,762 shares — an estimated $714K sold.

Citizens & Northern Corp first reported a position in AMGN in Q4 2014 and held it in 6 quarters. The position peaked at $1.27M in Q1 2015. 1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • Citizens & Northern Corp reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
  • Citizens & Northern Corp sold 4,762 Amgen shares in Q2 2016, an estimated $714K.
  • Citizens & Northern Corp first reported a position in Amgen in Q4 2014 and held it in 6 quarters.
  • Citizens & Northern Corp's Amgen position peaked at $1.27M in Q1 2015.
  • 1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Citizens & Northern Corp's 13F filing for Q2 2016, filed 10 Aug 2016.